Related references
Note: Only part of the references are listed.Retargeting Vesicular Stomatitis Virus Using Measles Virus Envelope Glycoproteins
Camilo Ayala-Breton et al.
HUMAN GENE THERAPY (2012)
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
Jose Pulido et al.
NATURE BIOTECHNOLOGY (2012)
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Jun Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels
A. Palumbo et al.
BRITISH JOURNAL OF CANCER (2011)
Clinical development directions in oncolytic viral therapy
R. M. Eager et al.
CANCER GENE THERAPY (2011)
Use of Macrophages to Target Therapeutic Adenovirus to Human Prostate Tumors
Munitta Muthana et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Interferon-stimulated gene ISG12b2 is localized to the inner mitochondrial membrane and mediates virus-induced cell death
M-Y Lu et al.
CELL DEATH AND DIFFERENTIATION (2011)
Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization
Elizabeth J. Ilett et al.
CLINICAL CANCER RESEARCH (2011)
Enhanced Safety Profiles of the Telomerase-Specific Replication-Competent Adenovirus by Incorporation of Normal Cell-Specific microRNA-Targeted Sequences
Kumiko Sugio et al.
CLINICAL CANCER RESEARCH (2011)
Phase I Clinical Study of Seneca Valley Virus (SVV-001), a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features
Charles M. Rudin et al.
CLINICAL CANCER RESEARCH (2011)
Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins
Houria Bachtarzi et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Variola and Monkeypox Viruses Utilize Conserved Mechanisms of Virion Motility and Release That Depend on Abl and Src Family Tyrosine Kinases
Patrick M. Reeves et al.
JOURNAL OF VIROLOGY (2011)
Pseudotyping Vesicular Stomatitis Virus with Lymphocytic Choriomeningitis Virus Glycoproteins Enhances Infectivity for Glioma Cells and Minimizes Neurotropism
Alexander Muik et al.
JOURNAL OF VIROLOGY (2011)
Pharmacological Interventions for Improving Adenovirus Usage in Gene Therapy
Hidde J. Haisma et al.
MOLECULAR PHARMACEUTICS (2011)
Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights
Bella Patel et al.
MOLECULAR THERAPY (2011)
Targeting Tumor Vasculature With an Oncolytic Virus
Caroline J. Breitbach et al.
MOLECULAR THERAPY (2011)
Sequential Therapy With JX-594, A Targeted Oncolytic Poxvirus, Followed by Sorafenib in Hepatocellular Carcinoma: Preclinical and Clinical Demonstration of Combination Efficacy
Jeong Heo et al.
MOLECULAR THERAPY (2011)
Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide
Alan Melcher et al.
MOLECULAR THERAPY (2011)
MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism
Mathias F. Leber et al.
MOLECULAR THERAPY (2011)
Active Adenoviral Vascular Penetration by Targeted Formation of Heterocellular Endothelial-epithelial Syncytia
Hannah H. Chen et al.
MOLECULAR THERAPY (2011)
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
Caroline J. Breitbach et al.
NATURE (2011)
A diverse range of gene products are effectors of the type I interferon antiviral response
John W. Schoggins et al.
NATURE (2011)
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors
Timothy Kottke et al.
NATURE MEDICINE (2011)
MicroRNA Controlled Adenovirus Mediates Anti-Cancer Efficacy without Affecting Endogenous MicroRNA Activity
Ryan Cawood et al.
PLOS ONE (2011)
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
Benjamin Diop-Frimpong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: Pathogenesis, prophylaxis, and antiviral therapy
Nanhai Chen et al.
VIROLOGY (2011)
HPMA copolymers for masking and retargeting of therapeutic viruses
Kerry D. Fisher et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Innate immune response and viral interference strategies developed by Human Herpesviruses
Patricia Vandevenne et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumor
J-C Tseng et al.
CANCER GENE THERAPY (2010)
Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study
J. Garcia-Castro et al.
CANCER GENE THERAPY (2010)
Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication
Brent J. Passer et al.
CANCER RESEARCH (2010)
Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with Rapamycin
XueQing Lun et al.
CANCER RESEARCH (2010)
Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
Evanthia Galanis et al.
CANCER RESEARCH (2010)
Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
Kevin J. Harrington et al.
CLINICAL CANCER RESEARCH (2010)
Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics
K. J. Harrington et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Combining oncolytic virotherapy and tumour vaccination
Byram W. Bridle et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus
Frederik C. Roos et al.
EMBO MOLECULAR MEDICINE (2010)
Oncolytic (replication-competent) adenoviruses as anticancer agents
Karoly Toth et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?
Ryuichi Kanai et al.
FUTURE ONCOLOGY (2010)
Infection and Killing of Multiple Myeloma by Adenoviruses
Julien S. Senac et al.
HUMAN GENE THERAPY (2010)
Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice
Timothy Kottke et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors
Pelagia Foka et al.
JOURNAL OF GENE MEDICINE (2010)
Attenuation of Vesicular Stomatitis Virus Encephalitis through MicroRNA Targeting
Elizabeth J. Kelly et al.
JOURNAL OF VIROLOGY (2010)
Transcriptional and Translational Dual-regulated Oncolytic Herpes Simplex Virus Type 1 for Targeting Prostate Tumors
Cleo Y. F. Lee et al.
MOLECULAR THERAPY (2010)
Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing
Fabrice Le Boeuf et al.
MOLECULAR THERAPY (2010)
A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus Sensitizers
Jean-Simon Diallo et al.
MOLECULAR THERAPY (2010)
Systemic Therapy of Disseminated Myeloma in Passively Immunized Mice Using Measles Virus-infected Cell Carriers
Chunsheng Liu et al.
MOLECULAR THERAPY (2010)
Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
Sonia Guedan et al.
MOLECULAR THERAPY (2010)
Delivering nanomedicine to solid tumors
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors
Heather MacTavish et al.
PLOS ONE (2010)
Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production
Tommy Alain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression
Li Yang et al.
TRENDS IN IMMUNOLOGY (2010)
Advances in mesenchymal stem cell-mediated gene therapy for cancer
Roisin M. Dwyer et al.
STEM CELL RESEARCH & THERAPY (2010)
Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model
Xiaoyang Ling et al.
CANCER MICROENVIRONMENT (2010)
Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular Architecture
Megan E. Fox et al.
ACCOUNTS OF CHEMICAL RESEARCH (2009)
Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis
Dominik E. Dorer et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor
Yuqi Jing et al.
CANCER RESEARCH (2009)
Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model
Emily K. Mader et al.
CLINICAL CANCER RESEARCH (2009)
Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2
Timothy Kottke et al.
CLINICAL CANCER RESEARCH (2009)
Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways
Shruthi Naik et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
E. J. Ilett et al.
GENE THERAPY (2009)
Cetuximab Retargeting of Adenovirus via the Epidermal Growth Factor Receptor for Treatment of Intraperitoneal Ovarian Cancer
Joanne Morrison et al.
HUMAN GENE THERAPY (2009)
Chemical Modification with High Molecular Weight Polyethylene Glycol Reduces Transduction of Hepatocytes and Increases Efficacy of Intravenously Delivered Oncolytic Adenovirus
Konstantin Doronin et al.
HUMAN GENE THERAPY (2009)
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Neil N. Senzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Systemic adenoviral gene delivery to orthotopic murine breast tumors with ablation of coagulation factors, thrombocytes and Kupffer cells
Anniina Koski et al.
JOURNAL OF GENE MEDICINE (2009)
Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay
Xiaoyi Yang et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
The p14 FAST Protein of Reptilian Reovirus Increases Vesicular Stomatitis Virus Neuropathogenesis
Christopher W. Brown et al.
JOURNAL OF VIROLOGY (2009)
Scavenger Receptor A: A New Route for Adenovirus 5
Hidde J. Haisma et al.
MOLECULAR PHARMACEUTICS (2009)
MicroRNAs and the Regulation of Vector Tropism
Elizabeth J. Kelly et al.
MOLECULAR THERAPY (2009)
Expanded Anticancer Therapeutic Window of Hexon-modified Oncolytic Adenovirus
Elena V. Shashkova et al.
MOLECULAR THERAPY (2009)
Intravascularly Administered RGD-Displaying Measles Viruses Bind to and Infect Neovessel Endothelial Cells In Vivo
Hooi Tin Ong et al.
MOLECULAR THERAPY (2009)
Conditional and reversible disruption of essential herpesvirus proteins
Mandy Glass et al.
NATURE METHODS (2009)
Use of Tissue-Specific MicroRNA to Control Pathology of Wild-Type Adenovirus without Attenuation of Its Ability to Kill Cancer Cells
Ryan Cawood et al.
PLOS PATHOGENS (2009)
Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer
David H. Kirn et al.
NATURE REVIEWS CANCER (2009)
Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus
Elena V. Shashkova et al.
CANCER RESEARCH (2008)
Enhancing poxvirus oncolytic effects through increased spread and immune evasion
David H. Kirn et al.
CANCER RESEARCH (2008)
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus
Jian Qiao et al.
CLINICAL CANCER RESEARCH (2008)
Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models
Shanthi Ganesh et al.
CLINICAL CANCER RESEARCH (2008)
Replication-competent retrovirus vectors for cancer gene therapy
Chien-Kuo Tai et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy
A. T. Power et al.
GENE THERAPY (2008)
Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors
J. Qiao et al.
GENE THERAPY (2008)
Development of PEGylated adenovirus vector with targeting ligand
Yusuke Eto et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation
Stephanie Oliere et al.
JOURNAL OF VIROLOGY (2008)
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
Byeong-Ho Park et al.
LANCET ONCOLOGY (2008)
Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate
Kenneth N. Barton et al.
MOLECULAR THERAPY (2008)
Histone deacetylase inhibitors augment antitumor efficacy of herpes-based oncolytic viruses
Akihiro Otsuki et al.
MOLECULAR THERAPY (2008)
Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor
Joanne Morrison et al.
MOLECULAR THERAPY (2008)
Treg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virus
Timothy Kottke et al.
MOLECULAR THERAPY (2008)
Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer
Timothy Kottke et al.
MOLECULAR THERAPY (2008)
A let-7 microRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication
Robert E. Edge et al.
MOLECULAR THERAPY (2008)
Exponential enhancement of oncolytic vesicular stomatitis virus potency by vector-mediated suppression of inflammatory responses in vivo
Jennifer Altomonte et al.
MOLECULAR THERAPY (2008)
Chemical control of protein stability and function in living mice
Laura A. Banaszynski et al.
NATURE MEDICINE (2008)
Engineering microRNA responsiveness to decrease virus pathogenicity
Elizabeth J. Kelly et al.
NATURE MEDICINE (2008)
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
Roberto Cattaneo et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
Irene Kuhn et al.
PLOS ONE (2008)
Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis
Thi Lien-Anh Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Herpes simplex virus type-I (HSV-I) oncolytic and highly fusogenic mutants carrying the NV1020 genomic deletion effectively inhibit primary and metastatic tumors in mice
Anna Israyelyan et al.
VIROLOGY JOURNAL (2008)
Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control
Mariam A. Stoff-Khalili et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Bioreactor production of recombinant herpes simplex virus vectors
David R. Knop et al.
BIOTECHNOLOGY PROGRESS (2007)
Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy
Kazuhiko Kurozumi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963
Steve H. Thorne et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Human reporter genes: potential use in clinical studies
Inna Serganova et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
Interferon, Mx, and viral countermeasures
Otto Haller et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2007)
Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin
Xue Qing Lun et al.
CANCER RESEARCH (2007)
Viruses as anticancer drugs
Stephen J. Russell et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus
Rosa Maria Diaz et al.
CANCER RESEARCH (2007)
Engineering oncolytic measles virus to circumvent the intracellular innate immune response
Iana Haralambieva et al.
MOLECULAR THERAPY (2007)
Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies
H. T. Ong et al.
GENE THERAPY (2007)
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Ta-Chiang Liu et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Stem cell collection and gene transfer in Fanconi anemia
Patrick F. Kelly et al.
MOLECULAR THERAPY (2007)
Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy
Joo-Hang Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules
Laura A. Banaszynski et al.
CELL (2006)
Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy
Dennis Hoffmann et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Synergistic antitumor effects of immune cell-viral biotherapy
SH Thorne et al.
SCIENCE (2006)
Rapid Kupffer cell death after intravenous injection of adenovirus vectors
E Manickan et al.
MOLECULAR THERAPY (2006)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
Rescue and propagation of fully retargeted oncolytic measles viruses
T Nakamura et al.
NATURE BIOTECHNOLOGY (2005)
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter
D Dingli et al.
BLOOD (2004)
Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus
NK Green et al.
GENE THERAPY (2004)
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity
HM Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum
MA Croyle et al.
JOURNAL OF VIROLOGY (2004)
Immune responses to gene therapy vectors: influence on vector function and effector mechanisms
N Bessis et al.
GENE THERAPY (2004)
In vivo imaging and tumor therapy with the sodium iodide symporter
D Dingli et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl et al.
CANCER CELL (2003)
Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: Virus persists and spreads systemically at late time points
H Sauthoff et al.
HUMAN GENE THERAPY (2003)
Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices
L Sanz et al.
GENE THERAPY (2002)
A single mutation in the E2 glycoprotein important for neurovirulence influences binding of Sindbis virus to neuroblastoma cells
PY Lee et al.
JOURNAL OF VIROLOGY (2002)
Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease
RJ Ziegler et al.
HUMAN GENE THERAPY (2002)
Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides
KW Peng et al.
NATURE MEDICINE (2002)
The complement response against an oncolytic virus is species-specific in its activation pathways
H Wakimoto et al.
MOLECULAR THERAPY (2002)
Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas
A Jacobs et al.
LANCET (2001)
Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma
RJ Wong et al.
HUMAN GENE THERAPY (2001)
Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver
NJ Tao et al.
MOLECULAR THERAPY (2001)
Blood clearance rates of adenovirus type 5 in mice
R Alemany et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
DF Stojdl et al.
NATURE MEDICINE (2000)
Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein
K Doronin et al.
JOURNAL OF VIROLOGY (2000)
Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant
K Ikeda et al.
JOURNAL OF VIROLOGY (2000)
Openings between defective endothelial cells explain tumor vessel leakiness
H Hashizume et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Large-plaque mutants of sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation
AP Byrnes et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
